Specifically, LSD1 mediates global EMT-related epigenetic reprogramming in mouse hepatocytes, thereby facilitating cell migration and chemoresistance23, and LSD1 promotes EMT, migration, and proliferation in NSCLC and hepatocellular carcinoma16,18. The gene discussed is KDM1A; the disease is non-small cell lung carcinoma.